Over 150 Total Lots Up For Auction at One Location - CA 05/31

Ionic Silver Complex Designed for Use in Humans Receives U.S. Patent

by Michael Johns, Project Manager | July 05, 2006

"'Nano silver' is the sexy new term for ionic silver," Newman said, "yet the imperative for an efficient delivery mechanism for human use is still the bottom line. Opti-Silver is nano silver with real science behind it to achieve that imperative. Having begun our intensive R&D efforts about ten years ago, we believe we are positioned at the leading edge of a large market that is just beginning to develop."

Silver 100 is sold primarily in health food stores at present, mainly in the eastern U.S., including some regions of Whole Foods. It is carried by United Natural Foods, the country's largest health foods distributor. Invision is rolling out national marketing and expects the product to be in the majority of health food stores, as well as supermarkets and pharmacies, by 2007.

For further information see www.silver100.com or contact the company at info@silver100.com. The U.S. Patent can be seen on the web site of the U.S. Patent & Trademark Office by going to http://www.silver100.com/USPatent.html.

About the Company

Invision International Health Solutions, Inc., a privately held company based in Fort Lauderdale, Florida, specializes in the research and development of ionic silver delivery solutions for human use. Because the patent covers a broad range of potential formulations, the company intends to pursue rigorous clinical studies, and FDA dietary supplement "health claims" approval as well as drug approval, for certain embodiments of the current patented technology and future technologies.

Jay Newman, the company's founder and President, has been interviewed as the industry expert on Good Morning America, NBC TV News, the Mining Industry Review, Wired News, and dozens of radio shows. He is a co-founding member of the Committee for the Responsible Use of Silver in Health, which is hosted at http://www.silverfacts.com. He is a co-inventor on the patent.

No studies have been conducted to either prove or disprove whether the patented technology delivers silver ions to the human body in a way that benefits the body. The statements herein have not been evaluated by the Food & Drug Administration. No product covered under the patent, or information thereon, is intended to diagnose, treat, cure or prevent any disease.

Silver 100 and Opti-Silver are trademarks of Invision International.

For the original story, use the link below:

Back to HCB News